Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

Fig. 1

Overall survival. Kaplan Meyer curves for PSA decline ≥ 30% and ≥ 50% at four, eight, and twelve weeks. In order, ≥30% PSA decline at four weeks (top left), ≥50% PSA decline at four weeks (top right), ≥30% PSA decline at eight weeks (middle left), ≥50% PSA decline at eight weeks (middle right), ≥30% PSA decline at twelve weeks (bottom left), and ≥ 50% PSA decline at twelve weeks (bottom right)

Back to article page